[Drug-drug interactions you should know!]

Area of Science:

• Pharmacology
• Clinical Medicine
• Drug Safety

Background:

• Polypharmacy is increasing due to multi-morbidity, leading to a rise in potential drug-drug interactions (DDIs).
• Understanding DDIs is crucial for managing patient safety in modern medicine.
• The complexity of DDIs requires accessible information for healthcare professionals.

Purpose of the Study:

• To review pharmacodynamic and pharmacokinetic drug-drug interactions (DDIs).
• To provide clinically relevant examples of DDIs.
• To offer practical tools for clinicians to identify and prevent DDIs.

Main Methods:

• Literature review of pharmacodynamic DDIs.
• Comprehensive review of pharmacokinetic DDIs, including cytochrome P450 and p-glycoprotein pathways.
• Compilation of tools and strategies for clinical practice.

Main Results:

• Detailed explanation of pharmacodynamic DDIs with examples.
• In-depth analysis of pharmacokinetic DDIs affecting drug plasma concentrations.
• Presentation of practical tools for DDI identification and prevention.

Conclusions:

• Increased awareness and prevention of DDIs are essential, especially in aging populations on polypharmacy.
• Effective management of DDIs can reduce patient mortality and morbidity.
• Clinicians can utilize provided tools to enhance patient safety by avoiding adverse drug events.